Bhia Mohammed, Motallebi Mahzad, Abadi Banafshe, Zarepour Atefeh, Pereira-Silva Miguel, Saremnejad Farinaz, Santos Ana Cláudia, Zarrabi Ali, Melero Ana, Jafari Seid Mahdi, Shakibaei Mehdi
Student Research Committee, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran 1996835113, Iran.
Nanomedicine Research Association (NRA), Universal Scientific Education and Research Network (USERN), Tehran 7616911319, Iran.
Pharmaceutics. 2021 Feb 23;13(2):291. doi: 10.3390/pharmaceutics13020291.
Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nanoemulsions. These nanomedicine formulations of NRG have been applied as a potential treatment for several diseases, using a wide range of in vitro, ex vivo, and in vivo models and different routes of administration. From this review, it can be concluded that NRG is a potential therapeutic option for the treatment of various diseases such as cancer, neurological disorders, liver diseases, ocular disorders, inflammatory diseases, skin diseases, and diabetes when formulated in the appropriate nanocarriers.
柚皮素(NRG)是一种属于黄烷酮类的多酚植物化学物质,广泛分布于柑橘类水果以及一些其他水果中,如佛手柑、番茄、可可和樱桃。NRG具有多种有趣的药理特性,如抗癌、抗氧化和抗炎活性。然而,由于其疏水性导致生物利用度差,NRG的治疗潜力受到阻碍。在此,我们综述了一系列已被用作NRG递送系统的纳米载体,包括聚合物纳米颗粒、胶束、脂质体、固体脂质纳米颗粒(SLN)、纳米结构脂质载体(NLC)、纳米混悬液和纳米乳剂。这些NRG的纳米药物制剂已被用作多种疾病的潜在治疗方法,采用了广泛的体外、离体和体内模型以及不同的给药途径。从这篇综述可以得出结论,当NRG以适当的纳米载体形式配制时,它是治疗各种疾病如癌症、神经疾病、肝脏疾病、眼部疾病、炎症性疾病、皮肤疾病和糖尿病的潜在治疗选择。